Loading...
OTC Markets
Totals
Securities
12,214
Dollar Vol
$2.7B
Share Vol
3.1B
Trades
358,241

OTC Markets Group uses cookies and similar technologies to help us understand how you use our websites, as further disclosed in our Privacy Policy. Our Terms of Service contain important information including restrictions on your use of our websites. By clicking “Accept”, or by continuing to use our websites, you consent to the use of cookies and agree to the terms of the OTC Markets Group Privacy Policy and Terms of Service.

OCS
Oculis Holding AG

Ordinary Shares

17.50

-0.67

-3.69%

Delayed (15 Min) Trade Data: 12:00am 07/18/2025
Oculis Holding AG Company Logo

Bahnhofstrasse 7

Zug CH-6300

Switzerland

Business Description
Oculis is a global biopharmaceutical company purposefully driven to save sight and improve eye care. Oculis' highly differentiated pipeline comprises multiple innovative product candidates in development. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. Headquartered in Switzerland and with operations in the US, Europe, and China, Oculis' goal is to deliver life-changing treatments to patients worldwide.
Financial Reporting
Reporting Status
U.S. Reporting: SEC Reporting
Audited Financials
Audited
Latest Report
CIK
0001953530
Fiscal Year End
12/31
Company Officers & Contacts

Not available

Board of Directors

Not available

Other Company Insiders

Not available

Other Company Insiders are all persons or entities beneficially owning 10% or more of any class of the issuer's securities. Together, officers, directors and other company insiders comprise Company Insiders.
Service Providers
Accounting/Auditing Firm
Marcum LLP

730 Third Ave

New York, NY 10017

Profile Data
SIC - Industry Classification
6770 - Blank Checks
Incorporation Information
Not Available
Employees
Not Available
Shell
No
Products and Services

Not available

Company Facilities

Not available

Nasdaq
Securities
Other Oculis Holding AG Securities
Daily Advancers
Subscribe to Our Newsletter
Stay up to date on the latest company news, industry trends and regulatory changes that affect our markets and learn about members of our community.